Damien Alan Perriman - 09 Oct 2026 Form 4 Insider Report for EXOZYMES INC. (EXOZ)

Reporting relationship: Chief Commercial Officer
Issuer ticker: EXOZ
Reported as of: 09 Oct 2026
Net transaction value: -$19,427
SEC form: 4
Accepted by SEC: 26 Oct 2026, 15:01:33 UTC
Prior SEC filing: 25 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Damien Perriman

Filing notes and source

Key filing fact

Damien Alan Perriman filed Form 4 for EXOZYMES INC. (EXOZ) on 26 Oct 2026.

Key facts

This page summarizes Damien Alan Perriman's Form 4 filing for EXOZYMES INC. (EXOZ).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Oct 2026, 15:01.

Change

Previous filing in this sequence was filed on 25 Aug 2026.
Current net transaction value: -$19,427.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002096714 Primary reporting owner

Perriman Damien Alan

Relationship: Chief Commercial Officer
Address: 750 ROYAL OAKS DRIVE /106, MONROVIA
Signature: /s/ Damien Perriman
Signature date: 26 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXOZ transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,922
Change %: +14%
Price
Shares after: 32,421
Date: 09 Oct 2026
Ownership: Direct
Footnotes: F1

EXOZ transaction

Common Stock

Sale

Transaction value: -$19,427
Shares: -3,729
Change %: -12%
Price: $5.21
Shares after: 28,692
Date: 12 Oct 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXOZ transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -3,922
Change %: -9.1%
Price: $0.000000^*
Shares after: 39,225
Date: 09 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,922
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The restricted stock units convert into common stock on a one-for-one basis. No consideration was paid by the reporting person on conversion.

Footnote F2

On April 1, 2026, the reporting person was granted an aggregate of 62,759 restricted stock units, vesting periodically.

Footnote F3

These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. The reported sale was effected in multiple trades at prices ranging from $5.15 to $5.25 per share. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.